business
Exagen Q1 Earnings Call Highlights
Key takeaways
- Exagen Q1 Earnings Call Highlights Market Beat Tue, May 12, 2026 at 12:09 AM GMT+7 7 min read XGN Exagen logo Key Points Interested in Exagen Inc.?
- Exagen posted record Q1 revenue of $17.3 million, up 12% year over year, and reaffirmed its full-year 2026 revenue guidance of $70 million to $73 million.
- Growth was driven by stronger testing volume and clinician adoption: AVISE CTD test volume rose 10% and ordering clinicians increased 15% to just over 2,700.
Exagen Q1 Earnings Call Highlights Market Beat Tue, May 12, 2026 at 12:09 AM GMT+7 7 min read XGN Exagen logo Key Points Interested in Exagen Inc.? Here are five stocks we like better.
Exagen posted record Q1 revenue of $17.3 million, up 12% year over year, and reaffirmed its full-year 2026 revenue guidance of $70 million to $73 million. Gross margin held at 59% while adjusted EBITDA loss improved to $2.2 million.
Growth was driven by stronger testing volume and clinician adoption: AVISE CTD test volume rose 10% and ordering clinicians increased 15% to just over 2,700. Management said winter storms temporarily disrupted some volume, but underlying demand remained strong.
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Also covered by
Investing.com
Earnings call transcript: Frontier Group Q1 2026 beats EPS forecast
Investing.com
Earnings call transcript: Marathon Petroleum beats Q1 2026 forecasts
Investing.com
Earnings call transcript: TSS Inc. Q1 2026 earnings beat forecasts but stock plunges
Investing.com
Earnings call transcript: Graphic Packaging’s Q1 2026 earnings exceed expectations
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop